Signal disagreement held before order.
Nova 380 Expansion regime detected across aligned market feeds.
Venue 02 Depth at 50 bps is 12% below the review window.
Portfolio BTC concentration is at 82% of the stated limit.
Turns signals into research briefs for a desk or client team. It cites the inputs, shows uncertainty and never places an order.
See how it works ↓Nova 380 Expansion regime detected across aligned market feeds.
Venue 02 Depth at 50 bps is 12% below the review window.
Portfolio BTC concentration is at 82% of the stated limit.
A trader can see a signal but still lose time reconstructing what moved, which evidence matters and how it affects the portfolio.
Atlas combines the signal with positions, stated limits and approved research, then separates observed facts from interpretation.
The team gets a concise, cited brief with uncertainty, scenarios and a clear hand-off to the person making the decision.
Evidence, interpretation and portfolio context remain separate all the way to the reader.
These are validation criteria for a scoped pilot. They are not presented as observed customer results.
Every material claim links to an approved source or market observation
The system states uncertainty and separates evidence from interpretation
No order is submitted and no risk limit is changed without an authorised workflow
Vocabulary and detail level remain consistent with the selected audience profile